HK40112940A - Covalent inhibitors of menin-mll interaction for diabetes mellitus - Google Patents

Covalent inhibitors of menin-mll interaction for diabetes mellitus Download PDF

Info

Publication number
HK40112940A
HK40112940A HK62024100995.5A HK62024100995A HK40112940A HK 40112940 A HK40112940 A HK 40112940A HK 62024100995 A HK62024100995 A HK 62024100995A HK 40112940 A HK40112940 A HK 40112940A
Authority
HK
Hong Kong
Prior art keywords
menin
diabetes mellitus
covalent inhibitors
mll interaction
mll
Prior art date
Application number
HK62024100995.5A
Other languages
Chinese (zh)
Inventor
Thomas Butler
James T. Palmer
Original Assignee
Biomea Fusion, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomea Fusion, Inc. filed Critical Biomea Fusion, Inc.
Publication of HK40112940A publication Critical patent/HK40112940A/en

Links

HK62024100995.5A 2021-08-11 2022-08-10 Covalent inhibitors of menin-mll interaction for diabetes mellitus HK40112940A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63/232,154 2021-08-11
US63/249,568 2021-09-28
US63/317,518 2022-03-07

Publications (1)

Publication Number Publication Date
HK40112940A true HK40112940A (en) 2025-01-28

Family

ID=

Similar Documents

Publication Publication Date Title
AU2022207648A9 (en) Isoindolinone compounds
CA3261302A1 (en) Heterocycle rbm39 modulators
EP4241773A4 (en) Pharmaceutical composition for treating leukemia comprising flt3 inhibitor
AU2024246994A1 (en) Methods for reducing exogenous insulin use
HK40112940A (en) Covalent inhibitors of menin-mll interaction for diabetes mellitus
CA3263420A1 (en) Fto inhibitors
CA3265189A1 (en) Inhibitors of myeloperoxidase
EP4144734A4 (en) Application of heterocyclic compound
HK40103863A (en) Isoindolinone compounds
CA3289111A1 (en) Treatment of diabetes mellitus
CA3270489A1 (en) Compounds for use as medicaments
CA3260086A1 (en) Compounds as myt1 inhibitors
HK40107059A (en) Certain fascin binding compounds for spinogenesis
CA3280853A1 (en) Inhibitors of synaptogyrin-3 expression
HK40118483A (en) Heterocyclic compounds as pi3ka inhibitors
CA3279320A1 (en) Compounds for fgfrs inhibitors
HK40104116A (en) Biosensor for determination of hemoglobin
HK40098679A (en) Substrate for single molecule organization
HK40123415A (en) Heterocyclic compounds capable of activating sting
CA3270840A1 (en) Heterocyclic compounds capable of activating sting
CA3266173A1 (en) Heterocyclic compounds capable of activating sting
HK40111748A (en) Use of heterocyclic compound
HK40092814A (en) Methods of treating diabetes
CA3280714A1 (en) Substituted 1h-pyrazole-4-carboxamides as sarm1 inhibitors
AU2024298839A1 (en) Pharmaceutical composition containing heterocyclic compound